3-Oxa-9-azoniatricyclo[3.3.1.02,4]nonane, 7-[(hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-, bromide, hydrate, (1α,2β,4β,5α,7β)- (9CI)
CAS: 139404-48-1
Ref. AN-AG001AYQ
| 1mg | Discontinued | ||
| 5mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued | ||
| 100mg | Discontinued |
Product Information
Name:
3-Oxa-9-azoniatricyclo[3.3.1.02,4]nonane, 7-[(hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-, bromide, hydrate, (1α,2β,4β,5α,7β)- (9CI)
Synonyms:
- [u'679 BR, BA', u'7-((hydroxybis(2-thienyl)acetyl)oxy)-9,9-dimethyl-3-oxa-9-azoniatricyclo(3.3.1.0(2,4))nonane bromide', u'BA 679 BR', u'BA-679 BR', u'BA679 BR', u'BR, BA 679', u'Bromide, Tiotropium', u'Spiriva', u'tiotropium', u'tiotropium bromide', u'Tiotropium bromide hydrate', u'139404-48-1', u'Tiotropium bromide monohydrate', u'Tiotropium bromide xhydrate', u'UNII-L64SXO195N', u'Tiotropium (bromide hydrate)', u'Spiriva', u'L64SXO195N', u'411207-31-3', u'BA-679-BR', u'6beta,7beta-Epoxy-3beta-hydroxy-8-methyl-1alphaH,5alphaH-tropanium bromide, di-2-thienylglycolate', u'(1?,2?,4?,5?,7?)-7-[(Hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromide hydrate', u'G00011-Watson-Int', u'Tiotropium-Bromide-hydrate', u'SCHEMBL155760', u'SCHEMBL1405692', u'CHEMBL3545181', u'Name: Tiotropium bromide hydrate', u'CHEBI:32230', u'C19H22NO4S2.Br.H2O', u'MQLXPRBEAHBZTK-SEINRUQRSA-M', u'BCP02924', u'HY-B0460', u'2759AH', u'CT0199', u'FC1259', u'MFCD08141831', u's2547', u'AKOS015900631', u'CS-2571', u'Tiotropium Bromide hydrate (BA679BR)', u'3-Oxa-9-azoniatricyclo(3.3.1.02,4)nonane, 7-((hydroxydi-2-thienylacetyl)oxy)-9,9-dimethyl-, bromide, hydrate, (1alpha,2beta,4beta,5alpha,7beta)-', u'AK161935', u'BC220523', u'FT-0080433', u'ST24050179', u'SW219041-1', u'(1a,2b,4b,5a,7b)-7-[(hydroxydi-2-thienylacety l)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromide hydrate', u'Tiotropium bromide monohydrate, >=98% (HPLC)', u'AB01568260_01', u'Tiotropium bromide monohydrate, European Pharmacopoeia (EP) Reference Standard', u'Tiotropium for system suitability 1, European Pharmacopoeia (EP) Reference Standard', u'(1alpha,2beta,4beta,5alpha,7beta)-7-[(hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0(2,4)]nonane bromide--water (1/1)', u'(1R,2R,4S,5S,7s)-7-(2-hydroxy-2,2-di(thiophen-2-yl)acetoxy)-9,9-dimethyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium bromide hydrate', u'3-Oxa-9-azoniatricyclo(3.3.1.02,4)nonane, 7-((hydroxydi-2-thienylacetyl)oxy)-9,9-dimethyl-, bromide, monohydrate, (1alpha,2beta,4beta,5alpha,7beta)-', u'3-Oxa-9-azoniatricyclo[3.3.1.02,4]nonane, 7-[(hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-, bromide, hydrate, (1alpha,2beta,4beta,5alpha,7beta)- (9CI)', u'Tiotropium Bromide Monohydrate, Pharmaceutical Secondary Standard; Certified Reference Material', u'Spiriva Respimat', u'TIOTROPIUM BROMIDE', u'Tiotropiumbromidehydrate', u'BA 679BR', u'C19H22NO4S2.Br.xH2O', u'CID11431811', u'C19-H22-N-O4-S2.Br.x-H2-O', u'2984H', u'B1619', u'(1a,2b,4b,5a,7b)-7-((hydroxydi-2-thienylacety l)oxy)-9,9-dimethyl-3-oxa-9-azoniatricyclo(3.3.1.02,4)nonane bromide hydrate']
- (1R,2R,4S,5S,7S)-7-{[hydroxy(dithiophen-2-yl)acetyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromide hydrate (1:1:1)
- 7-{[Hydroxy(Dithiophen-2-Yl)Acetyl]Oxy}-9,9-Dimethyl-3-Oxa-9-Azoniatricyclo[3.3.1.02,4]Nonane Bromide Hydrate (1:1:1)
- Tiotropium Bromide Monohydrate
CAS:
Brand:
Indagoo
Long term storage:
Notes:
Chemical properties
Molecular weight:
490.4316
Formula:
C19H24BrNO5S2
Purity:
98%
Color/Form:
Solid
InChI:
InChI=1S/C19H22NO4S2.BrH.H2O/c1-20(2)12-9-11(10-13(20)17-16(12)24-17)23-18(21)19(22,14-5-3-7-25-14)15-6-4-8-26-15;;/h3-8,11-13,16-17,22H,9-10H2,1-2H3;1H;1H2/q+1;;/p-1/t11?,12-,13+,16-,17+;;
InChI key:
MQLXPRBEAHBZTK-KFEMZTBUSA-M
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
